Support for the AstraZeneca vaccine was expressed by the Health Service of Canada, Health Canada, after the European Medicines Agency (EMA), saying that this vaccine is not associated with an increase in the overall risk of developing blood clots.
“Health Canada confirms the benefits of the AstraZeneca vaccine in protecting them Of Canada from COVID-19 continue to outweigh the risks “, the regulatory authority states in a statement issued yesterday, Thursday, as broadcast by AMPE.
“To this day in Canada there has been a report of stroke which occurred in a human after vaccination, “the Canadian regulator added. “This case was evaluated by Health Canada and found to be unrelated to the vaccine.”
Health Canada also noted that it evaluated available data on cases and determined that this vaccine was not associated with an increase in the overall risk of developing blood clots.
Canada uses its doses AstraZeneca vaccine /University of Oxford prepared at the Serum Institute of India. The country has received 500,000 doses of the vaccine and expects to receive another 1.5 million by May.
(file photo)
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
